AI Tokens
Stock Analysis on Net

McKesson Corp. (NYSE:MCK)

This company has been moved to the archive! The financial data has not been updated since October 27, 2016.

Analysis of Profitability Ratios

Microsoft Excel

Profitability Ratios (Summary)

Return on Sales

Return on Investment

McKesson Corp., profitability ratios

Microsoft Excel
Mar 31, 2016 Mar 31, 2015 Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Return on Sales
Gross profit margin 5.98% 6.37% 6.04% 5.70% 5.35% 5.33%
Operating profit margin 1.86% 1.66% 1.72% 1.89% 1.75% 1.62%
Net profit margin 1.18% 0.82% 0.92% 1.09% 1.14% 1.07%
Return on Investment
Return on equity (ROE) 25.30% 18.45% 14.82% 18.93% 20.54% 16.65%
Return on assets (ROA) 3.99% 2.74% 2.44% 3.85% 4.24% 3.89%

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).


The profitability profile from 2011 to 2016 is characterized by narrow margins and a significant expansion in shareholder returns. While core margins remained relatively constrained, there was a notable increase in the efficiency of equity utilization toward the end of the period.

Profit Margin Trends
Gross profit margin exhibited a steady upward trajectory from 5.33% in 2011 to a peak of 6.37% in 2015, before retreating slightly to 5.98% in 2016. In contrast, operating profit margins remained remarkably stable, fluctuating within a narrow band between 1.62% and 1.89%. Net profit margins showed more volatility, experiencing a gradual decline from 1.14% in 2012 to a low of 0.82% in 2015, followed by a recovery to 1.18% in 2016. This divergence suggests that while gross profitability improved for several years, those gains were largely offset by operating expenses or non-operating costs.
Return on Investment Metrics
Return on equity (ROE) demonstrated substantial growth and volatility, starting at 16.65% in 2011 and reaching a period high of 25.30% by 2016. A notable dip occurred in 2014, where ROE fell to 14.82%, before rebounding strongly. Return on assets (ROA) followed a similar pattern of volatility but at a lower magnitude, peaking at 4.24% in 2012 and hitting a low of 2.44% in 2014, eventually recovering to 3.99% in 2016.
Efficiency and Leverage Insights
The significant spread between the Return on Equity and the Return on Assets indicates a consistent reliance on financial leverage to amplify returns for shareholders. The synchronization of the troughs in ROE and ROA in 2014 suggests a systemic decline in asset productivity during that fiscal year, while the sharp increase in ROE in 2016, coupled with a stabilizing net profit margin, points to improved capital efficiency or changes in the equity structure.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Gross Profit Margin

McKesson Corp., gross profit margin calculation, comparison to benchmarks

Microsoft Excel
Mar 31, 2016 Mar 31, 2015 Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Selected Financial Data (US$ in millions)
Gross profit 11,416 11,411 8,309 6,984 6,567 5,970
Revenues 190,884 179,045 137,609 122,455 122,734 112,084
Profitability Ratio
Gross profit margin1 5.98% 6.37% 6.04% 5.70% 5.35% 5.33%
Benchmarks
Gross Profit Margin, Competitors2
Abbott Laboratories — — — — — —
Elevance Health Inc. — — — — — —
Intuitive Surgical Inc. — — — — — —
Medtronic PLC — — — — — —
UnitedHealth Group Inc. — — — — — —

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).

1 2016 Calculation
Gross profit margin = 100 × Gross profit ÷ Revenues
= 100 × 11,416 ÷ 190,884 = 5.98%

2 Click competitor name to see calculations.


The financial performance from 2011 to 2016 is characterized by substantial growth in both top-line revenue and gross profit. Total revenues increased from 112,084 million US$ in 2011 to 190,884 million US$ in 2016, while gross profit grew from 5,970 million US$ to 11,416 million US$ over the same period.

Revenue and Gross Profit Scaling
A consistent upward trajectory is observed in total revenues, with a particularly significant acceleration occurring between 2014 and 2015, during which revenue grew by approximately 30%. Gross profit followed a similar expansionary path, nearly doubling across the six-year window.
Gross Profit Margin Expansion
The gross profit margin demonstrated a period of steady improvement from 2011 through 2015, rising from 5.33% to a peak of 6.37%. This trend indicates an increase in operational efficiency or a more favorable shift in the product and service mix.
Margin Contraction in 2016
A reversal in the margin trend occurred in 2016, where the gross profit margin declined to 5.98% despite continued revenue growth. This suggests that the cost of sales increased at a higher rate than revenue during the final fiscal year of the analyzed period.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Operating Profit Margin

McKesson Corp., operating profit margin calculation, comparison to benchmarks

Microsoft Excel
Mar 31, 2016 Mar 31, 2015 Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Selected Financial Data (US$ in millions)
Operating income 3,545 2,968 2,367 2,315 2,149 1,821
Revenues 190,884 179,045 137,609 122,455 122,734 112,084
Profitability Ratio
Operating profit margin1 1.86% 1.66% 1.72% 1.89% 1.75% 1.62%
Benchmarks
Operating Profit Margin, Competitors2
Abbott Laboratories — — — — — —
Elevance Health Inc. — — — — — —
Intuitive Surgical Inc. — — — — — —
Medtronic PLC — — — — — —
UnitedHealth Group Inc. — — — — — —

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).

1 2016 Calculation
Operating profit margin = 100 × Operating income ÷ Revenues
= 100 × 3,545 ÷ 190,884 = 1.86%

2 Click competitor name to see calculations.


An analysis of the operational performance from 2011 to 2016 reveals a consistent expansion in both total revenue and operating income, although the operating profit margin remained within a narrow and fluctuating range.

Revenue and Operating Income Growth
A strong upward trajectory is observed in top-line growth, with revenues increasing from 112,084 million USD in 2011 to 190,884 million USD by 2016. This growth was accompanied by a steady rise in operating income, which nearly doubled over the six-year period, rising from 1,821 million USD to 3,545 million USD.
Operating Profit Margin Trends
The operating profit margin exhibited a non-linear trend, characterized by a period of improvement followed by a slight contraction and a subsequent recovery. The margin increased from 1.62% in 2011 to a peak of 1.89% in 2013. This was followed by a decline to 1.72% in 2014 and a further dip to 1.66% in 2015, before rebounding to 1.86% in 2016.
Operational Efficiency and Scalability
A significant surge in revenue occurred between 2014 and 2015, increasing by approximately 30%, yet the operating profit margin decreased during this same window. This suggests that the costs associated with the rapid scaling of operations temporarily outpaced the growth in operating income. However, the recovery to 1.86% in 2016 indicates a successful realignment of operational expenses relative to the increased revenue base.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Net Profit Margin

McKesson Corp., net profit margin calculation, comparison to benchmarks

Microsoft Excel
Mar 31, 2016 Mar 31, 2015 Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Selected Financial Data (US$ in millions)
Net income attributable to McKesson Corporation 2,258 1,476 1,263 1,338 1,403 1,202
Revenues 190,884 179,045 137,609 122,455 122,734 112,084
Profitability Ratio
Net profit margin1 1.18% 0.82% 0.92% 1.09% 1.14% 1.07%
Benchmarks
Net Profit Margin, Competitors2
Abbott Laboratories — — — — — —
Elevance Health Inc. — — — — — —
Intuitive Surgical Inc. — — — — — —
Medtronic PLC — — — — — —
UnitedHealth Group Inc. — — — — — —

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).

1 2016 Calculation
Net profit margin = 100 × Net income attributable to McKesson Corporation ÷ Revenues
= 100 × 2,258 ÷ 190,884 = 1.18%

2 Click competitor name to see calculations.


Between the fiscal years ending March 31, 2011, and March 31, 2016, the organization experienced substantial top-line growth accompanied by fluctuating net profit margins. While revenues increased consistently, the ability to translate that growth into net profit exhibited a period of compression before a significant recovery in the final year.

Revenue Trajectory
Total revenues grew from US$ 112,084 million in 2011 to US$ 190,884 million in 2016. A notable acceleration in growth is observed between 2014 and 2015, during which revenues increased from US$ 137,609 million to US$ 179,045 million, indicating a significant expansion in business volume.
Net Income Performance
Net income attributable to the corporation showed volatility between 2011 and 2015, fluctuating between US$ 1,202 million and US$ 1,476 million. This period of relative stagnation was followed by a sharp increase in 2016, where net income reached US$ 2,258 million, the highest absolute value in the period analyzed.
Net Profit Margin Trends
The net profit margin peaked at 1.14% in 2012 before entering a period of steady decline, reaching a minimum of 0.82% in 2015. This downward trend suggests that expenses grew at a disproportionate rate relative to revenue growth during those years. However, this trend was reversed in 2016, with the margin expanding to 1.18%, surpassing the previous peak and signaling a recovery in overall profitability efficiency.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Return on Equity (ROE)

McKesson Corp., ROE calculation, comparison to benchmarks

Microsoft Excel
Mar 31, 2016 Mar 31, 2015 Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Selected Financial Data (US$ in millions)
Net income attributable to McKesson Corporation 2,258 1,476 1,263 1,338 1,403 1,202
Total McKesson Corporation stockholders’ equity 8,924 8,001 8,522 7,070 6,831 7,220
Profitability Ratio
ROE1 25.30% 18.45% 14.82% 18.93% 20.54% 16.65%
Benchmarks
ROE, Competitors2
Abbott Laboratories — — — — — —
Elevance Health Inc. — — — — — —
Intuitive Surgical Inc. — — — — — —
Medtronic PLC — — — — — —
UnitedHealth Group Inc. — — — — — —

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).

1 2016 Calculation
ROE = 100 × Net income attributable to McKesson Corporation ÷ Total McKesson Corporation stockholders’ equity
= 100 × 2,258 ÷ 8,924 = 25.30%

2 Click competitor name to see calculations.


The financial performance between 2011 and 2016 is characterized by an overall increase in profitability and efficiency in generating shareholder returns, despite period-specific volatility.

Net Income Trends
Net income demonstrated a general upward trajectory, rising from US$ 1,202 million in 2011 to US$ 2,258 million by 2016. A period of moderate contraction occurred between 2012 and 2014, with income dipping to US$ 1,263 million, followed by a sharp and significant acceleration in earnings during the 2015 and 2016 fiscal years.
Stockholders' Equity Evolution
Total stockholders' equity fluctuated throughout the period, starting at US$ 7,220 million in 2011 and ending at US$ 8,924 million in 2016. The most notable increase occurred between 2013 and 2014, while a slight contraction was observed in 2015, indicating shifts in the company's capital structure or retained earnings strategy.
Return on Equity (ROE) Analysis
ROE exhibited significant variance, beginning at 16.65% in 2011 and reaching a peak of 25.30% in 2016. A trough was observed in 2014 at 14.82%, a decline driven by the simultaneous occurrence of lower net income and higher total equity. The substantial recovery to 25.30% in 2016 reflects a strong improvement in the conversion of equity into profit, primarily driven by the surge in net income attributable to the corporation.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Return on Assets (ROA)

McKesson Corp., ROA calculation, comparison to benchmarks

Microsoft Excel
Mar 31, 2016 Mar 31, 2015 Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Selected Financial Data (US$ in millions)
Net income attributable to McKesson Corporation 2,258 1,476 1,263 1,338 1,403 1,202
Total assets 56,563 53,870 51,759 34,786 33,093 30,886
Profitability Ratio
ROA1 3.99% 2.74% 2.44% 3.85% 4.24% 3.89%
Benchmarks
ROA, Competitors2
Abbott Laboratories — — — — — —
Elevance Health Inc. — — — — — —
Intuitive Surgical Inc. — — — — — —
Medtronic PLC — — — — — —
UnitedHealth Group Inc. — — — — — —

Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).

1 2016 Calculation
ROA = 100 × Net income attributable to McKesson Corporation ÷ Total assets
= 100 × 2,258 ÷ 56,563 = 3.99%

2 Click competitor name to see calculations.


Between fiscal years 2011 and 2016, the return on assets (ROA) exhibited a volatile trajectory, characterized by an initial period of relative stability, a significant contraction, and a subsequent recovery.

Asset Base Expansion
Total assets grew from US$ 30,886 million in 2011 to US$ 56,563 million by 2016. A substantial increase occurred between 2013 and 2014, where the asset base expanded by approximately 48.7%. This rapid growth in assets preceded the period of lowest asset efficiency, as the ROA declined to 2.44% in 2014 and remained suppressed at 2.74% in 2015.
Net Income Performance
Net income remained relatively consistent from 2011 to 2015, fluctuating within a range of US$ 1,202 million to US$ 1,476 million. However, a sharp increase was recorded in 2016, with net income rising to US$ 2,258 million. This significant growth in bottom-line profitability offset the continued increase in total assets, driving the ROA back up to 3.99%.
ROA Trend Analysis
The ROA reached a peak of 4.24% in 2012 before entering a downward trend that bottomed out in 2014. The decline during this period indicates that asset growth outpaced income growth. The recovery observed in 2016 suggests an improvement in operational efficiency or the successful integration of assets acquired during the previous expansion phase, returning the ROA to a level nearly equivalent to the 2011 starting point.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?